SCAGLIONE, ILARIA MARIANGELA
 Distribuzione geografica
Continente #
AS - Asia 80
EU - Europa 76
NA - Nord America 66
AF - Africa 2
SA - Sud America 2
Totale 226
Nazione #
US - Stati Uniti d'America 60
SG - Singapore 37
IT - Italia 35
CN - Cina 28
RU - Federazione Russa 11
HK - Hong Kong 10
CA - Canada 6
DE - Germania 5
FR - Francia 5
IE - Irlanda 5
FI - Finlandia 4
SE - Svezia 4
BE - Belgio 3
AT - Austria 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
ID - Indonesia 1
IN - India 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
MY - Malesia 1
NL - Olanda 1
TG - Togo 1
TN - Tunisia 1
Totale 226
Città #
Singapore 31
Verona 21
Chandler 12
Hong Kong 10
New York 6
Dublin 5
Ann Arbor 4
Ashburn 4
Toronto 4
Brussels 3
Jacksonville 3
Milan 3
Padova 3
Beijing 2
Frankfurt am Main 2
Helsinki 2
Jinan 2
Munich 2
Ottawa 2
Pieve Emanuele 2
Quanzhou 2
San Giovanni Lupatoto 2
Santa Clara 2
Shenyang 2
Tianjin 2
Zhengzhou 2
Boardman 1
Chicago 1
Columbus 1
Guangzhou 1
Jakarta 1
Lawrence 1
Lomé 1
Princeton 1
Quito 1
Redmond 1
Sacramento 1
Seattle 1
Seoul 1
Sindelfingen 1
Taiyuan 1
Taizhou 1
Tokyo 1
Vienna 1
Totale 153
Nome #
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 90
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 35
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 28
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 19
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents 15
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 15
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions 12
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 12
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 10
Totale 236
Categoria #
all - tutte 1.423
article - articoli 1.423
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/202119 2 3 1 2 0 2 0 7 0 0 2 0
2021/202216 1 3 0 0 1 1 0 0 1 1 2 6
2022/202330 1 3 3 5 1 8 0 3 6 0 0 0
2023/202448 1 0 1 3 21 6 6 1 0 3 3 3
2024/2025119 11 4 11 73 8 12 0 0 0 0 0 0
Totale 236